Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

Dual antiplatelet therapy with aspirin and a P2Y12 receptor inhibitor represents the cornerstone therapy for patients with acute coronary syndromes or undergoing percutaneous interventions, leading to a reduction of subsequent ischemic events. Variable response to clopidogrel has received close atte...

Full description

Bibliographic Details
Main Authors:	Adriana Dana Oprea, Wanda M. Popescu
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Cardiology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2013/195456

Similar Items

WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. Yu. Gilyarov, et al.
Published: (2018-05-01)

Capsule Endoscopy: What We Know and What Is New in the Horizon
by: Virender Chauhan, et al.
Published: (2019-04-01)

What is new in 2015 ESC nonST Elevation Acute Coronary Syndrome Guideline?
by: Aylin Yıldırır
Published: (2016-02-01)

New Drug Treatments for Osteoarthritis: What is on the Horizon
by: Fiona E. Watt, et al.
Published: (2017-03-01)

What is new on the horizon in melanoma brain metastasis?
by: Kim Margolin
Published: (2019-09-01)

P2Y<sub>12</sub> Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel
by: N. M. Vorobyeva
Published: (2019-01-01)

What is beyond the horizon?
by: Lai, Xiu Li, et al.
Published: (1996)

Coronary heart disease treatment: old principles and new horizons
by: Yu. A. Vasyuk, et al.
Published: (2007-02-01)

New Antithrombotic Drugs in Acute Coronary Syndrome
by: Bastiaan Zwart, et al.
Published: (2020-06-01)

New horizons for lipoprotein receptors: communication by β-propellers
by: Olav M. Andersen, et al.
Published: (2013-10-01)

THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR
by: S. R. Gilyarevsky, et al.
Published: (2014-07-01)

THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR
by: S. R. Gilyarevsky, et al.
Published: (2014-07-01)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors
by: Patricia P. Wadowski, et al.
Published: (2019-07-01)

Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors
by: Fersing Cyril, et al.
Published: (2022-03-01)

Acute coronary syndromes
by: Bergmark, B.A, et al.
Published: (2022)

Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
by: Tingting Li, et al.
Published: (2021-01-01)

Association between Angiotensin-Converting Enzyme Inhibitors and Troponin in Acute Coronary Syndrome
by: Luiz Minuzzo, et al.
Published: (2014-12-01)

P2Y12 inhibitors for acute coronary syndromes: current perspectives
by: Nawarskas JJ, et al.
Published: (2015-10-01)

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?
by: María Asunción Esteve-Pastor, et al.
Published: (2016-02-01)

To Be or Not to Be … Acute Coronary Syndrome
by: Irina Pintilie, et al.
Published: (2016-09-01)

Acute Coronary Syndromes
Published: (2012)

New organisational strategies in acute coronary syndrome management
by: L. S. Barbarash, et al.
Published: (2011-10-01)

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?
by: Matthew A Silva, et al.
Published: (2006-03-01)

Coronary Arterial Stenting in Acute Coronary Syndrome
by: S. O. Sokolova, et al.
Published: (2006-02-01)

Coronary ectasia in a man on breast cancer therapy presenting with acute coronary syndrome
by: Dana C Johnson, et al.
Published: (2016-10-01)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
by: Passiglia F, et al.
Published: (2021-02-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome.
by: Zhi-Jiang Xie, et al.
Published: (2021-01-01)

Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines
by: Paul Guedeney, et al.
Published: (2020-10-01)

Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of acute coronary syndrome and in transcutaneous coronary interventions
by: D V Fettser, et al.
Published: (2009-03-01)

Biomarkers in Acute Coronary Syndrome
by: Valentina Loria, et al.
Published: (2008-01-01)

Biomarkers in Acute Coronary Syndrome
by: Valentina Loria, et al.
Published: (2008-01-01)

IL-23/IL-17 INHIBITORS IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES: NEW HORIZONS
by: E. L. Nasonov, et al.
Published: (2019-09-01)

Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
by: Mădălina Ioana Moisi, et al.
Published: (2020-03-01)

The predictive value of soluble osteoclast-associated receptor for the prognosis of acute coronary syndrome
by: Rong Wang, et al.
Published: (2021-06-01)

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.
by: Fidel Manuel Cáceres Lóriga, et al.
Published: (2001-01-01)

New Horizons
by: Karen Nelson, et al.
Published: (2012-08-01)

Acute Coronary Syndrome in Pregnancy
by: Douglas Wright, et al.
Published: (2009-01-01)

Acute Coronary Syndrome in Pregnancy
by: Douglas Wright, et al.
Published: (2009-12-01)

Neutrophils in Acute Coronary Syndrome
by: Rahul Kurup, et al.
Published: (2017-10-01)